Neurogene shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Neurogene
Tip: Access up to 7 years of quarterly data
All positions including Neurogene held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurogene by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $11M | 481k | 22.86 |
| 2024-09-30 | $192k | 4.6k | 41.96 |
| 2024-06-30 | $160k | 4.4k | 36.39 |
| 2024-03-31 | $509 | 10 | 50.90 |
| 2023-12-31 | $194 | 10 | 19.40 |